Seyed Amir Hossein Batouli Dr. *1,
Minoo Sisakhti Ms.2,
Shirin Haghshenas Bilehsavar Dr.2,
Hamed Dehghani Mr.2,
Perminder Sachdev Prof.3,
Hamed Ekhtiari Dr.4,
Nicole Kochan Prof.3,
Wei Wen Prof.3,
Alexander Leemans Prof.5,
Mohsen Kohanpour Mr.6,
Mohammad Ali Oghabian Prof.7
1- Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
2- NeuroImaging and Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
3- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
4- Laureate Institute for Brain Research, Tulsa, OK, USA
5- Image Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands
6- Neuroimaging and Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
7- Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:
The Iranian Brain Imaging Database (IBID) was initiated in 2017, with five major aims: provide researchers easy access to a neuroimaging database; provide normative quantitative measures of the brain for clinical research purposes; study the ageing profile of the brain; examine the association of brain structure and function; and join the ENIGMA consortium. Many prestigious databases with similar aims are available; however, they are not on an Iranian population, and the battery of their tests (e.g., cognitive tests) is selected based on their specific questions and needs. The IBID will include 300 participants (50% female) in the age range of 20 to 70 years old, with an equal number of participants (#60) in each age decade. It comprises a battery of cognitive, lifestyle, medical, and mental health tests, in addition to several MRI protocols. Each participant completes the assessments on two referral days. The study currently has a cross-sectional design, but longitudinal assessments are considered for the future phases of the study. Here, details of the methodology, along with the initial results of assessing the first 152 participants of the study, are provided. IBID is established to enable research into human brain function, to aid clinicians for disease diagnosis researches, and also to unite the Iranian researchers with interests in the brain
Type of Study:
Original |
Subject:
Cognitive Neuroscience Received: 2019/05/1 | Accepted: 2019/08/21 | Published: 2018/03/15